Literature DB >> 6505708

Hairy cell leukemia: clinical presentation and follow-up of 211 patients.

G Flandrin, F Sigaux, G Sebahoun, P Bouffette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6505708

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  13 in total

1.  [Therapeutic procedure in hairy cell leukemia].

Authors:  P von Wussow
Journal:  Klin Wochenschr       Date:  1987-07-15

Review 2.  Hairy cell leukemia: clinical features and therapeutic advances.

Authors:  B C Lembersky; H M Golomb
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  [Diagnosis and prognosis of hairy cell leukemia].

Authors:  W Hill; G Kettner; R Burkhardt
Journal:  Klin Wochenschr       Date:  1987-07-15

4.  Primary treatment of hairy cell leukemia: should IFN-therapy replace splenectomy?

Authors:  F Porzsolt
Journal:  Blut       Date:  1986-05

5.  Platelet-adjusted IFN dosage in the treatment of advanced hairy cell leukemia.

Authors:  F Porzsolt; J Thomä; M Unsöld; W Wolf; H J Obert; B Kubanek; H Heimpel
Journal:  Blut       Date:  1985-08

6.  Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years.

Authors:  Fergün Yılmaz; Dilan Atilla; Nagihan Akkaş; Hale Bülbül; Nur Soyer; Derya Demir; Demet Kiper; Aylin Avcı; Filiz Vural; Güray Saydam; Fahri Şahin; Mine Hekimgil; Nazan Özsan; Raika Durusoy; Bahriye Payzın
Journal:  Indian J Hematol Blood Transfus       Date:  2019-05-13       Impact factor: 0.900

7.  [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].

Authors:  N Niederle; C Doberauer; O Kloke; K Höffken; C G Schmidt
Journal:  Klin Wochenschr       Date:  1987-07-15

Review 8.  Hairy cell leukemia.

Authors:  Claire Dearden; Monica Else
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

Review 9.  Interferon-alpha in malignant and viral diseases. A review.

Authors:  R T Dorr
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

10.  [Splenectomy: surgical indications in malignant hematologic diseases].

Authors:  F Harder; C Honegger; M Dürig
Journal:  Langenbecks Arch Chir       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.